History
Drug Watch International is a volunteer, non-profit, drug information network and advocacy organization that promotes the creation of drug-free healthy cultures in the world and opposes the legalization of drugs. The organization upholds a comprehensive approach to drug issues, involving prevention, education, research, intervention, treatment, law enforcement, and interdiction.
The purpose of Drug Watch is to provide the public, policy makers, and the media with current information, factual research, and expert resources; and to counter drug-advocacy propaganda. An active, highly informed Board of Directors governs Drug Watch International and coordinates a network of delegates from across the United States and over 25 nations, a Liaison Network of representatives from international, national, and state prevention and treatment organizations, a Board of Advisors, and the prestigious International Drug Strategy Institute.
The International Drug Strategy Institute, a division of Drug Watch International, is a bipartisan group of physicians, attorneys, educators, law enforcement officials, and drug prevention specialists who provide expertise on national and international drug research. The Institute pursues research and public policy on drug issues consistent with the comprehensive approach established by Drug Watch International.
Drug Watch International was founded September 14, 1991, in Chicago, Illinois.
Present were:
Joan Bellm … Carlinville, Illinois (Founder)
Rosanna Creighton … Portland, Oregon (Public Policy Expert)
Otto Moulton … Danvers, Massachusetts (Drug Culture Expert)
David Noffs … Chicago, Illinois (International Prevention Foundation)
Bob Peterson … Lansing, Michigan (Attorney)
David Noffs was elected the first President of Drug Watch International.
The International Drug Strategy Institute was formed February 13, 1993, in St. Louis, Missouri. Eric Voth, MD, FACP, was appointed the Director. The Institute pursues research and public policy on drug issues consistent with the comprehensive approach established by Drug Watch International.
